Reason for the notification
|
|
|||||||
Initial notification /Amendment
|
Initial notification
|
|
||||||
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|||||||
Name
|
Smith & Nephew plc
|
|
||||||
LEI
|
213800ZTMDN8S67S1H61
|
|
||||||
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|||||||
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
|
||||||
Identification code
|
ISIN: GB0009223206
|
|
||||||
Nature of the transaction
|
Vesting of Smith & Nephew Global Share Plan 2010 Performance
Share Programme awards granted on 7 March 2018.
|
|
||||||
Date of Transaction
|
2021 - 03 - 08
|
|
||||||
Place of Transaction
|
London Stock Exchange (XLON)
|
|
||||||
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Total Ordinary Share Holding following the transaction
*
|
Total Ordinary Share Holding as a % of the Company's ISC following
the transaction *
|
||
Bradley Cannon
(President Sports Medicine & ENT)
|
PDMR
|
13.4385
|
8,123 (of which 3,616 were sold and 4,507 retained)
|
N/A Single Transaction
|
69762.76313 ordinary shares (including 2,101.64550 in
ADS')
|
0.00788%
|
||
Phil Cowdy
(Chief Business Development & Corporate Affairs
Officer)
|
PDMR
|
13.4385
|
3,869 (of which 1,825 were sold and 2,044 retained)
|
N/A Single Transaction
|
37,044.19975 ordinary shares
|
0.00419%
|
||
Elga Lohler
(Chief HR Officer)
|
PDMR
|
13.4385
|
6,185 (of which 2,443 were sold and 3,742 retained)
|
N/A Single Transaction
|
93,097.00000 ordinary shares (including 3,105.00000 in
ADS')
|
0.01052%
|
||
Catheryn O'Rourke
(Chief Legal & Compliance Officer)
|
PDMR
|
13.4385
|
6,129 (of which 2,089 were sold and 4,040 retained)
|
N/A Single Transaction
|
66,886.23565 ordinary shares (including 5,818.25734 in
ADS')
|
0.00756%
|
||
Vasant Padmanabhan
(President Research & Development)
|
PDMR
|
13.4385
|
6,966 (of which 2,365 were sold and 4,601 retained)
|
N/A Single Transaction
|
49,890.00000 ordinary shares
|
0.00564%
|
||
Susan Swabey
(Company Secretary)
|
PDMR
|
13.4385
|
2,727 (of which 1,287 were sold and 1,440 retained)
|
N/A Single Transaction
|
45,759.83952 ordinary shares
|
0.00517%
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Final vesting of Equity Incentive Programme awards granted on 7
March 2018 under the Smith & Nephew Global Share Plan
2010.
|
Date of Transaction
|
2021 - 03 - 08
|
Place of Transaction
|
London Stock Exchange (XLON)
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Total Ordinary Share Holding following the transaction
*
|
Total Ordinary Share Holding as a % of the Company's ISC following
the transaction *
|
Bradley Cannon
(President Sports Medicine & ENT)
|
PDMR
|
13.4385
|
5,240 (of which 2,333 were sold and 2,907 retained)
|
N/A Single Transaction
|
72,669.76313 ordinary shares (including 2,101.64550 in
ADS')
|
0.00821%
|
Phil Cowdy
(Chief Business Development & Corporate Affairs
Officer)
|
PDMR
|
13.4385
|
3,089 (of which 1,457 were sold and 1,632 retained)
|
N/A Single Transaction
|
38,676.19975 ordinary shares
|
0.00437%
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
13.4385
|
4,389 (of which 1,734 were sold and 2,655 retained)
|
N/A Single Transaction
|
95,752.00000 ordinary shares (including 3,105.00000 in
ADS')
|
0.01082%
|
Catheryn O'Rourke
(Chief Legal & Compliance Officer)
|
PDMR
|
13.4385
|
4,350 (of which 1,483 were sold and 2,867 retained)
|
N/A Single Transaction
|
69,753.23565 ordinary shares (including 5,818.25734 in
ADS')
|
0.00788%
|
Vasant Padmanabhan
(President Research & Development)
|
PDMR
|
13.4385
|
4,494 (of which 1,526 were sold and 2,968 retained)
|
N/A Single Transaction
|
52,858.00000 ordinary shares
|
0.00597%
|
Susan Swabey
(Company Secretary)
|
PDMR
|
13.4385
|
1,936 (of which 914 were sold and 1,022 retained)
|
N/A Single Transaction
|
46,781.83952 ordinary shares
|
0.00529%
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Partial vesting of Equity Incentive Programme awards granted on 7
March 2019 under the Smith & Nephew Global Share Plan
2010.
|
Date of Transaction
|
2021 - 03 - 08
|
Place of Transaction
|
London Stock Exchange (XLON)
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Total Ordinary Share Holding following the transaction
*
|
Total Ordinary Share Holding as a % of the Company's ISC following
the transaction *
|
Bradley Cannon
(President Sports Medicine & ENT)
|
PDMR
|
13.4385
|
4,859 (of which 2,162 were sold and 2,697 retained)
|
N/A Single Transaction
|
75,366.76313 ordinary shares (including 2,101.64550 in
ADS')
|
0.00852%
|
Phil Cowdy
(Chief Business Development & Corporate Affairs
Officer)
|
PDMR
|
13.4385
|
2,423 (of which 1,143 were sold and 1,280 retained)
|
N/A Single Transaction
|
39,956.19975 ordinary shares
|
0.00452%
|
Mark Gladwell
(President Operations & GBS)
|
PDMR
|
13.4385
|
2,268 (of which 1,070 were sold and 1,198 retained)
|
N/A Single Transaction
|
2,801.44339 ordinary shares
|
0.00032%
|
Melissa Guerdan
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
13.4385
|
1,927 (of which 658 were sold and 1,269 retained)
|
N/A Single Transaction
|
2,551.42336 ordinary shares
|
0.00029%
|
Skip Kiil
(President Orthopaedics)
|
PDMR
|
13.4385
|
6,143 (of which 2,350 were sold and 3,793 retained)
|
N/A Single Transaction
|
3,793.53744 ordinary shares
|
0.00043%
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
13.4385
|
4,608 (of which 1,819 were sold and 2,789 retained)
|
N/A Single Transaction
|
98,541.00000 ordinary shares (including 3,105.00000 in
ADS')
|
0.01114%
|
Catheryn O'Rourke
(Chief Legal & Compliance Officer)
|
PDMR
|
13.4385
|
4,471 (of which 1,524 were sold and 2,947 retained)
|
N/A Single Transaction
|
72,700.23565 ordinary shares (including 5,818.25734 in
ADS')
|
0.00822%
|
Vasant Padmanabhan
(President Research & Development)
|
PDMR
|
13.4385
|
4,167 (of which 1,414 were sold and 2,753 retained)
|
N/A Single Transaction
|
55,611.00000 ordinary shares
|
0.00628%
|
Susan Swabey
(Company Secretary)
|
PDMR
|
13.4385
|
1,699 (of which 801 were sold and 898 retained)
|
N/A Single Transaction
|
47,679.83952 ordinary shares
|
0.00539%
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Grant of supplementary conditional share award on 8 March 2021
under the Smith & Nephew Global Share Plan 2020 relating to the
2018 Performance Share Programme awards.
|
Date of Transaction
|
2021 - 03 - 08
|
Place of Transaction
|
Grant took place outside a trading venue
|
Name
(Position)
|
Status
|
Price (£)
|
Volume(s)*
|
Aggregated information
|
Bradley Cannon
(President Sports Medicine & ENT)
|
PDMR
|
Nil
|
3,740
|
N/A Single Transaction
|
Phil Cowdy
(Chief Business Development & Corporate Affairs
Officer)
|
PDMR
|
Nil
|
1,781
|
N/A Single Transaction
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
Nil
|
2,848
|
N/A Single Transaction
|
Catheryn O'Rourke (Chief Legal & Compliance
Officer)
|
PDMR
|
Nil
|
2,823
|
N/A Single Transaction
|
Vasant Padmanabhan (President Research &
Development)
|
PDMR
|
Nil
|
3,207
|
N/A Single Transaction
|
Susan Swabey (Company Secretary)
|
PDMR
|
Nil
|
1,255
|
N/A Single Transaction
|
Total:
|
-
|
Nil
|
15,654
|
-
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Grant of supplementary conditional share award on 8 March 2021
under the Smith & Nephew Global Share Plan 2020 relating to the
2019 Performance Share Programme awards.
|
Date of Transaction
|
2021 - 03 - 08
|
Place of Transaction
|
Grant took place outside a trading venue
|
Name
(Position)
|
Status
|
Price (£)
|
Volume(s)*
|
Aggregated information
|
Bradley Cannon (President Sports Medicine & ENT)
|
PDMR
|
Nil
|
7,696
|
N/A Single Transaction
|
Phil Cowdy
(Chief Business Development & Corporate Affairs
Officer)
|
PDMR
|
Nil
|
5,641
|
N/A Single Transaction
|
Simon Fraser
(President Advanced Wound Management)
|
PDMR
|
Nil
|
6,791
|
N/A Single Transaction
|
Mark Gladwell (President Operations & GBS)
|
PDMR
|
Nil
|
6,581
|
N/A Single Transaction
|
Melissa Guerdan
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
Nil
|
6,291
|
N/A Single Transaction
|
Skip Kiil
(President Orthopaedics)
|
PDMR
|
Nil
|
9,722
|
N/A Single Transaction
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
Nil
|
6,680
|
N/A Single Transaction
|
Catheryn O'Rourke
(Chief Legal & Compliance Officer)
|
PDMR
|
Nil
|
6,495
|
N/A Single Transaction
|
Vasant Padmanabhan (President Research &
Development)
|
PDMR
|
Nil
|
6,595
|
N/A Single Transaction
|
Susan Swabey (Company Secretary)
|
PDMR
|
Nil
|
2,446
|
N/A Single Transaction
|
Total:
|
-
|
Nil
|
64,938
|
-
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Grant of supplementary conditional share award on 8 March 2021
under the Smith & Nephew Global Share Plan 2020 relating to the
2020 Performance Share Programme Awards.
|
Date of Transaction
|
2021 - 03 - 08
|
Place of Transaction
|
Grant took place outside a trading venue
|
Name
(Position)
|
Status
|
Price (£)
|
Volume(s)*
|
Aggregated information
|
Bradley Cannon (President Sports Medicine& ENT)
|
PDMR
|
Nil
|
7,406
|
N/A Single Transaction
|
Phil Cowdy
(Chief Business Development & Corporate Affairs
Officer)
|
PDMR
|
Nil
|
4,965
|
N/A Single Transaction
|
Myra Eskes
(President APAC Region)
|
PDMR
|
Nil
|
7,348
|
N/A Single Transaction
|
Simon Fraser (President Advanced Wound
Management)
|
PDMR
|
Nil
|
6,407
|
N/A Single Transaction
|
Mark Gladwell (President Operations & GBS)
|
PDMR
|
Nil
|
6,620
|
N/A Single Transaction
|
Melissa Guerdan (Chief Quality & Regulatory Affairs
Officer)
|
PDMR
|
Nil
|
6,113
|
N/A Single Transaction
|
Skip Kiil
(President Orthopaedics)
|
PDMR
|
Nil
|
9,172
|
N/A Single Transaction
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
Nil
|
6,618
|
N/A Single Transaction
|
Catheryn O'Rourke
(Chief Legal & Compliance Officer)
|
PDMR
|
Nil
|
6,434
|
N/A Single Transaction
|
Vasant Padmanabhan (President Research &
Development)
|
PDMR
|
Nil
|
6,409
|
N/A Single Transaction
|
Susan Swabey (Company Secretary)
|
PDMR
|
Nil
|
2,206
|
N/A Single Transaction
|
Total:
|
-
|
Nil
|
69,698
|
-
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Equity Incentive Programme awards granted on 9 March 2021 under the
Smith & Nephew Global Share Plan 2020.
|
Date of Transaction
|
2021 - 03 - 09
|
Place of Transaction
|
Grant took place outside a trading venue
|
Name
(Position)
|
Status
|
Price (s)
|
Volume(s)
|
Aggregated information
|
Bradley Cannon
(President Sports Medicine & ENT)
|
PDMR
|
£13.65
|
19,632
|
N/A Single Transaction
|
Peter Coenen
(President EMEA Region)
|
PDMR
|
£13.65
|
4,908
|
N/A Single Transaction
|
Phil Cowdy
(Chief Business Development & Corporate Affairs
Officer)
|
PDMR
|
£13.65
|
15,744
|
N/A Single Transaction
|
Myra Eskes
(President APAC Region)
|
PDMR
|
£13.65
|
17,131
|
N/A Single Transaction
|
Simon Fraser
(President Advanced Wound Management)
|
PDMR
|
£13.65
|
14,233
|
N/A Single Transaction
|
Mark Gladwell
(President Operations & GBS)
|
PDMR
|
£13.65
|
19,809
|
N/A Single Transaction
|
Melissa Guerdan
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
£13.65
|
13,844
|
N/A Single Transaction
|
Skip Kiil
(President Orthopaedics)
|
PDMR
|
£13.65
|
20,377
|
N/A Single Transaction
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
£13.65
|
17,543
|
N/A Single Transaction
|
Catheryn O'Rourke
(Chief Legal & Compliance Officer)
|
PDMR
|
£13.65
|
15,516
|
N/A Single Transaction
|
Vasant Padmanabhan
(President Research & Development)
|
PDMR
|
£13.65
|
14,546
|
N/A Single Transaction
|
Susan Swabey
(Company Secretary)
|
PDMR
|
£13.65
|
6,917
|
N/A Single Transaction
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc Ordinary Shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Conditional share awards granted on 9 March 2021 under the Smith
& Nephew Global Share Plan 2020.
|
Date of Transaction
|
2021 - 03 - 09
|
Place of Transaction
|
Grant took place outside a trading venue
|
Name
(Position)
|
Status
|
Price (s)
|
Volume(s)
|
Aggregated information
|
Mark Gladwell
(President Operations & GBS)
|
PDMR
|
£13.65
|
30,476
|
N/A Single Transaction
|
Skip Kiil
(President Orthopaedics)
|
PDMR
|
£13.65
|
37,049
|
N/A Single Transaction
|